Pliant Therapeutics, Inc. Common Stock (PLRX) is a publicly traded Healthcare sector company. As of July 13, 2026, PLRX trades at $1.13 with a market cap of $69.35M and a P/E ratio of -0.46. PLRX moved +0.89% today. Year to date, PLRX is -7.44%; over the trailing twelve months it is -20.00%. Its 52-week range spans $1.09 to $15.80. Analyst consensus is neutral with an average price target of $2.67. Rallies surfaces PLRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover PLRX: 0 strong buy, 1 buy, 4 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $2.67.
| Metric | Value |
|---|---|
| Price | $1.13 |
| Market Cap | $69.35M |
| P/E Ratio | -0.46 |
| EPS | $-2.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.80 |
| 52-Week Low | $1.09 |
| Volume | 1.10M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-149.34M |
| Gross Margin | 0.00% |
5 analysts cover PLRX: 0 strong buy, 1 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.67.